Daruka Mahadevan (D Mahadevan)

Publication Activity (10 Years)

Years Active: 2017-2019
Publications (10 Years): 3

Top Topics

Multiple Myeloma

Top Venues

Cancer chemotherapy and pharmacology

Journal for immunotherapy of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Daruka Mahadevan, Mark C Lanasa, Charles Farber, Manjari Pandey, Maria Whelden, Susan J Faas, Terrie Ulery, Anjli Kukreja, Lan Li, Camille L Bedrosian, Xiaoping Zhang, Leonard T Heffner
Phase I study of samalizumab in chronic lymphocytic leukemia and multiple myeloma: blockade of the immune checkpoint CD200. Journal for immunotherapy of cancer 7 (1) (2019)
Michael A Badruddoja, Marjorie Pazzi, Abhay Sanan, Kurt Schroeder, Kevin Kuzma, Thomas Norton, Thomas Scully, Daruka Mahadevan, Michael Malek Ahmadi
Phase II study of bi-weekly temozolomide plus bevacizumab for adult patients with recurrent glioblastoma. Cancer chemotherapy and pharmacology 80 (4) (2017)
Daruka Mahadevan, Monica Mita, Donald Richards, Edward McClay, Rebecca Suk Heist, A Kumar, S Sundararajan, Aung Naing
Phase I single dose, two-period and two-sequence cross-over trial to evaluate the relative bioavailability of two oral pimasertib formulations in advanced cancer patients. Cancer chemotherapy and pharmacology 79 (4) (2017)